{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T11:44:31Z","timestamp":1794570271464,"version":"4.9.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T00:00:00Z","timestamp":1521763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T00:00:00Z","timestamp":1521763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Aminoglycosides are commonly used for the treatment of pulmonary exacerbations in patients with cystic fibrosis (CF). However, they are potentially nephrotoxic. This prospective observational cohort study aimed to investigate the potential validity of two urinary renal biomarkers, Kidney Injury Molecule-1 (KIM-1) and Neutrophil Gelatinase-associated Lipocalin (NGAL), in identifying aminoglycoside-induced nephrotoxicity in children with CF. Children and young adults up to 20 years of age with a confirmed diagnosis of CF were recruited from ten United Kingdom hospitals. Participants provided urine samples for measurement of KIM-1 and NGAL concentrations, at baseline, at regular outpatient appointments, and before, during and after exposure to clinically-indicated treatment with the aminoglycoside tobramycin. 37\/158 patients recruited (23.4%) received at least one course of IV tobramycin during the study. The median peak fold-change during tobramycin exposure for KIM-1 was 2.28 (IQR 2.69) and 4.02 (IQR 7.29) for NGAL, in the absence of serum creatinine changes. Baseline KIM-1 was positively associated with cumulative courses of IV aminoglycosides (R<jats:sup>2<\/jats:sup>\u2009=\u20090.11; \u03b2\u2009=\u20090.03; p\u2009&lt;\u20090.0001). KIM-1, in particular, may be a useful, non-invasive, biomarker of acute and chronic proximal tubular injury associated with exposure to aminoglycosides in patients with CF, but its clinical utility needs to be further evaluated in prospective studies.<\/jats:p>","DOI":"10.1038\/s41598-018-23466-4","type":"journal-article","created":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T01:39:24Z","timestamp":1522287564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Urinary Biomarkers of Aminoglycoside-Induced Nephrotoxicity in Cystic Fibrosis: Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0509-7425","authenticated-orcid":false,"given":"Stephen J.","family":"McWilliam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Antoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalind L.","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munir","family":"Pirmohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,23]]},"reference":[{"key":"23466_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1056\/NEJM199607183350307","volume":"335","author":"BW Ramsey","year":"1996","unstructured":"Ramsey, B. W. Management of pulmonary disease in patients with cystic fibrosis. The New England journal of medicine 335, 179\u2013188 (1996).","journal-title":"The New England journal of medicine"},{"key":"23466_CR2","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1136\/thx.2006.067595","volume":"62","author":"C Bertenshaw","year":"2007","unstructured":"Bertenshaw, C., Watson, A. R., Lewis, S. & Smyth, A. Survey of acute renal failure in patients with cystic fibrosis in the UK. Thorax 62, 541\u2013545 (2007).","journal-title":"Thorax"},{"key":"23466_CR3","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1136\/thx.2007.088757","volume":"63","author":"A Smyth","year":"2008","unstructured":"Smyth, A. et al. Case-control study of acute renal failure in patients with cystic fibrosis in the UK. Thorax 63, 532\u2013535 (2008).","journal-title":"Thorax"},{"key":"23466_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00467-016-3471-9","volume":"32","author":"JA Saban","year":"2017","unstructured":"Saban, J. A., Pizzi, M., Caldwell, J., Palijan, A. & Zappitelli, M. Previous aminoglycoside use and acute kidney injury risk in non-critically ill children. Pediatr. Nephrol. 32, 173\u2013179, https:\/\/doi.org\/10.1007\/s00467-016-3471-9 (2017).","journal-title":"Pediatr. Nephrol."},{"key":"23466_CR5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jcf.2014.03.005","volume":"13","author":"KJ Downes","year":"2014","unstructured":"Downes, K. J. et al. Daily serum creatinine monitoring promotes earlier detection of acute kidney injury in children and adolescents with cystic fibrosis. Journal of Cystic Fibrosis 13, 435\u2013441, https:\/\/doi.org\/10.1016\/j.jcf.2014.03.005 (2014).","journal-title":"Journal of Cystic Fibrosis"},{"key":"23466_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/ppul.20138","volume":"39","author":"M Al-Aloul","year":"2005","unstructured":"Al-Aloul, M. et al. Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use. Pediatr. Pulmonol. 39, 15\u201320 (2005).","journal-title":"Pediatr. Pulmonol."},{"key":"23466_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00467-008-1060-2","volume":"24","author":"DJ Askenazi","year":"2009","unstructured":"Askenazi, D. J., Ambalavanan, N. & Goldstein, S. L. Acute kidney injury in critically ill newborns: what do we know? What do we need to learn? Pediatr. Nephrol. 24, 265\u2013274 (2009).","journal-title":"Pediatr. Nephrol."},{"key":"23466_CR8","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1681\/ASN.2008070669","volume":"20","author":"SS Waikar","year":"2009","unstructured":"Waikar, S. S. & Bonventre, J. V. Creatinine Kinetics and the Definition of Acute Kidney Injury. J. Am. Soc. Nephrol. 20, 672\u2013679, https:\/\/doi.org\/10.1681\/asn.2008070669 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"23466_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nbt.1625","volume":"28","author":"F Dieterle","year":"2010","unstructured":"Dieterle, F. et al. Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium. Nat. Biotechnol. 28, 455\u2013462, https:\/\/doi.org\/10.1038\/nbt.1625 (2010).","journal-title":"Nat. Biotechnol."},{"key":"23466_CR10","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/nbt.1623","volume":"28","author":"VS Vaidya","year":"2010","unstructured":"Vaidya, V. S. et al. Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat. Biotechnol. 28, 478\u2013485 (2010).","journal-title":"Nat. Biotechnol."},{"key":"23466_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1159\/000078452","volume":"24","author":"J Mishra","year":"2004","unstructured":"Mishra, J. et al. Neutrophil gelatinase-associated lipocalin: A novel early urinary biomarker for cisplatin nephrotoxicity. Am. J. Nephrol. 24, 307\u2013315, https:\/\/doi.org\/10.1159\/000078452 (2004).","journal-title":"Am. J. Nephrol."},{"key":"23466_CR12","doi-asserted-by":"publisher","first-page":"e43809","DOI":"10.1371\/journal.pone.0043809","volume":"7","author":"SJ McWilliam","year":"2012","unstructured":"McWilliam, S. J. et al. Mechanism-based urinary biomarkers to identify the potential for aminoglycoside-induced nephrotoxicity in premature neonates: A proof-of-concept study. PLoS ONE 7, e43809 (2012).","journal-title":"PLoS ONE"},{"key":"23466_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.1","volume":"2","author":"JA Kellum","year":"2012","unstructured":"Kellum, J. A. et al. Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney International Supplements 2, 1\u2013138, https:\/\/doi.org\/10.1038\/kisup.2012.1 (2012).","journal-title":"Kidney International Supplements"},{"key":"23466_CR14","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.jcf.2015.07.012","volume":"15","author":"AP Prayle","year":"2016","unstructured":"Prayle, A. P. et al. The pharmacokinetics and toxicity of morning vs. evening tobramycin dosing for pulmonary exacerbations of cystic fibrosis: A randomised comparison. Journal of Cystic Fibrosis 15, 510\u2013517, https:\/\/doi.org\/10.1016\/j.jcf.2015.07.012 (2016).","journal-title":"Journal of Cystic Fibrosis"},{"key":"23466_CR15","first-page":"A278","volume":"45","author":"AZ Uluer","year":"2010","unstructured":"Uluer, A. Z. et al. Urinary biomarkers for early detection of nephrotoxicity in cystic fibrosis. Pediatr. Pulmonol. 45, A278 (2010).","journal-title":"Pediatr. Pulmonol."},{"key":"23466_CR16","doi-asserted-by":"publisher","DOI":"10.2217\/bmm.14.36","author":"SJ McWilliam","year":"2014","unstructured":"McWilliam, S. J. et al. Reference intervals for urinary renal injury biomarkers KIM-1 and NGAL in healthy children. Biomarkers in medicine. https:\/\/doi.org\/10.2217\/bmm.14.36 (2014).","journal-title":"Biomarkers in medicine"},{"key":"23466_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/ppul.22795","volume":"49","author":"T Lahiri","year":"2014","unstructured":"Lahiri, T., Guillet, A., Diehl, S. & Ferguson, M. High-dose ibuprofen is not associated with increased biomarkers of kidney injury in patients with cystic fibrosis. Pediatr. Pulmonol. 49, 148\u2013153, https:\/\/doi.org\/10.1002\/ppul.22795 (2014).","journal-title":"Pediatr. Pulmonol."},{"key":"23466_CR18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000335579","volume":"35","author":"L Gardiner","year":"2012","unstructured":"Gardiner, L. et al. Structural Equation Modeling Highlights the Potential of Kim-1 as a Biomarker for Chronic Kidney Disease. Am. J. Nephrol. 35, 152\u2013163 (2012).","journal-title":"Am. J. Nephrol."},{"key":"23466_CR19","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1093\/ndt\/gfr023","volume":"26","author":"PC Xu","year":"2011","unstructured":"Xu, P. C. et al. Urinary kidney injury molecule-1 in patients with IgA nephropathy is closely associated with disease severity. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association 26, 3229\u20133236 (2011).","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"23466_CR20","doi-asserted-by":"publisher","unstructured":"Xu, P. C. et al. Urinary kidney injury molecule-1 is related to pathologic involvement in IgA nephropathy with normotension, normal renal function and mild proteinuria. BMC Nephrology 15, https:\/\/doi.org\/10.1186\/1471-2369-15-107 (2014).","DOI":"10.1186\/1471-2369-15-107"},{"key":"23466_CR21","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1093\/ndt\/gfr135","volume":"26","author":"HPE Peters","year":"2011","unstructured":"Peters, H. P. E. et al. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy. Nephrology Dialysis Transplantation 26, 3581\u20133588, https:\/\/doi.org\/10.1093\/ndt\/gfr135 (2011).","journal-title":"Nephrology Dialysis Transplantation"},{"key":"23466_CR22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10157-012-0707-2","volume":"17","author":"SH Kwon","year":"2013","unstructured":"Kwon, S. H. et al. KIM-1 expression predicts renal outcomes in IgA nephropathy. Clinical and Experimental Nephrology 17, 359\u2013364, https:\/\/doi.org\/10.1007\/s10157-012-0707-2 (2013).","journal-title":"Clinical and Experimental Nephrology"},{"key":"23466_CR23","doi-asserted-by":"publisher","first-page":"F885","DOI":"10.1152\/ajprenal.00331.2013","volume":"306","author":"Q Lin","year":"2014","unstructured":"Lin, Q. et al. Kidney injury molecule-1 expression in IgA nephropathy and its correlation with hypoxia and tubulointerstitial inflammation. Am. J. Physiol. Renal. Physiology. 306, F885\u2013F895, https:\/\/doi.org\/10.1152\/ajprenal.00331.2013 (2014).","journal-title":"Am. J. Physiol. Renal. Physiology."},{"key":"23466_CR24","doi-asserted-by":"publisher","unstructured":"Seo, M. S. et al. Effect of treatment on urinary kidney injury molecule-1 in IgA nephropathy. BMC Nephrology 14, https:\/\/doi.org\/10.1186\/1471-2369-14-139 (2013).","DOI":"10.1186\/1471-2369-14-139"},{"key":"23466_CR25","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1515\/cclm-2014-0655","volume":"53","author":"JAM De Carvalho","year":"2015","unstructured":"De Carvalho, J. A. M. et al. Evaluation of the diagnostic characteristics of urinary kidney injury molecule 1 (uKIM-1) and uKIM-1\/creatinine ratio in the assessment of incipient diabetic kidney disease. Clin. Chem. Lab. Med. 53, e51\u2013e54, https:\/\/doi.org\/10.1515\/cclm-2014-0655 (2015).","journal-title":"Clin. Chem. Lab. Med."},{"key":"23466_CR26","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/ki.2010.404","volume":"79","author":"VS Vaidya","year":"2011","unstructured":"Vaidya, V. S. et al. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-\u0392-D-glucosaminidase. Kidney Int. 79, 464\u2013470, https:\/\/doi.org\/10.1038\/ki.2010.404 (2011).","journal-title":"Kidney Int."},{"key":"23466_CR27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.trre.2010.02.002","volume":"24","author":"W Huo","year":"2010","unstructured":"Huo, W., Zhang, K., Nie, Z., Li, Q. & Jin, F. Kidney injury molecule-1 (KIM-1): a novel kidney-specific injury molecule playing potential double-edged functions in kidney injury. Transplant. Rev. 24, 143\u2013146, https:\/\/doi.org\/10.1016\/j.trre.2010.02.002 (2010).","journal-title":"Transplant. Rev."},{"key":"23466_CR28","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1172\/JCI34487","volume":"118","author":"T Ichimura","year":"2008","unstructured":"Ichimura, T. et al. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J. Clin. Invest. 118, 1657\u20131668, https:\/\/doi.org\/10.1172\/JCI34487 (2008).","journal-title":"J. Clin. Invest."},{"key":"23466_CR29","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1203\/PDR.0b013e3181baa3dd","volume":"66","author":"TK Huynh","year":"2009","unstructured":"Huynh, T. K. et al. Reference values of urinary neutrophil gelatinase-associated lipocalin in very low birth weight infants. Pediatr. Res. 66, 528\u2013532 (2009).","journal-title":"Pediatr. Res."},{"key":"23466_CR30","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1203\/PDR.0b013e3182275164","volume":"70","author":"DJ Askenazi","year":"2011","unstructured":"Askenazi, D. J. et al. Baseline values of candidate urine acute kidney injury biomarkers vary by gestational age in premature infants. Pediatr. Res. 70, 302\u2013306 (2011).","journal-title":"Pediatr. Res."},{"key":"23466_CR31","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1515\/cclm-2013-0157","volume":"51","author":"V Pennemans","year":"2013","unstructured":"Pennemans, V. et al. Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: Are age and gender an issue? Clin. Chem. Lab. Med. 51, 1795\u20131802 (2013).","journal-title":"Clin. Chem. Lab. Med."},{"key":"23466_CR32","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.cca.2012.09.022","volume":"415","author":"X Zhang","year":"2013","unstructured":"Zhang, X. et al. Analytical and biological validation of a multiplex immunoassay for acute kidney injury biomarkers. Clin. Chim. Acta 415, 88\u201393 (2013).","journal-title":"Clin. Chim. Acta"},{"key":"23466_CR33","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1258\/acb.2011.011105","volume":"49","author":"MR Cullen","year":"2012","unstructured":"Cullen, M. R., Murray, P. T. & Fitzgibbon, M. C. Establishment of a reference interval for urinary neutrophil gelatinase-associated lipocalin. Ann. Clin. Biochem. 49, 190\u2013193 (2012).","journal-title":"Ann. Clin. Biochem."},{"key":"23466_CR34","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.febslet.2004.12.031","volume":"579","author":"V Hvidberg","year":"2005","unstructured":"Hvidberg, V. et al. The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett. 579, 773\u2013777, https:\/\/doi.org\/10.1016\/j.febslet.2004.12.031 (2005).","journal-title":"FEBS Lett."},{"key":"23466_CR35","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3109\/0886022X.2014.996109","volume":"37","author":"A Suchojad","year":"2015","unstructured":"Suchojad, A. et al. Factors limiting usefulness of serum and urinary NGAL as a marker of acute kidney injury in preterm newborns. Ren. Fail. 37, 439\u2013445, https:\/\/doi.org\/10.3109\/0886022X.2014.996109 (2015).","journal-title":"Ren. Fail."},{"key":"23466_CR36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/pr.2015.62","volume":"78","author":"JM Pynn","year":"2015","unstructured":"Pynn, J. M. et al. Urinary neutrophil gelatinase-associated lipocalin: Potential biomarker for late-onset sepsis. Pediatr. Res. 78, 76\u201381, https:\/\/doi.org\/10.1038\/pr.2015.62 (2015).","journal-title":"Pediatr. Res."},{"key":"23466_CR37","doi-asserted-by":"crossref","unstructured":"Zughaier, S. M., Tangpricha, V., Leong, T., Stecenko, A. A. & McCarty, N. A. Peripheral monocytes derived from patients with cystic fibrosis and healthy donors secrete ngal in response to pseudomonas aeruginosa infection. J. Investig. Med. 61, 1018\u20131025, 10.231\/JIM.0b013e31829cbd14 (2013).","DOI":"10.2310\/JIM.0b013e31829cbd14"},{"key":"23466_CR38","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/S0022-3476(76)81125-0","volume":"88","author":"GJ Schwartz","year":"1976","unstructured":"Schwartz, G. J., Haycock, G. B., Chir, B. & Spitzer, A. Plasma creatinine and urea concentration in children: Normal values for age and sex. The Journal of Pediatrics 88, 828\u2013830, https:\/\/doi.org\/10.1016\/S0022-3476(76)81125-0 (1976).","journal-title":"The Journal of Pediatrics"},{"key":"23466_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft, D. W. & Gault, M. H. Prediction of creatinine clearance from serum creatinine. Nephron 16, 31\u201341 (1976).","journal-title":"Nephron"},{"key":"23466_CR40","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jcf.2010.03.006","volume":"9","author":"A Andrieux","year":"2010","unstructured":"Andrieux, A. et al. Renal impairment in children with cystic fibrosis. Journal of Cystic Fibrosis 9, 263\u2013268 (2010).","journal-title":"Journal of Cystic Fibrosis"},{"key":"23466_CR41","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.2215\/CJN.01640309","volume":"4","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz, G. J. & Work, D. F. Measurement and estimation of GFR in children and adolescents. Clinical journal of the American Society of Nephrology: CJASN 4, 1832\u20131843 (2009).","journal-title":"Clinical journal of the American Society of Nephrology: CJASN"},{"key":"23466_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jcf.2006.05.004","volume":"6","author":"M Al-Aloul","year":"2007","unstructured":"Al-Aloul, M., Jackson, M., Bell, G., Ledson, M. & Walshaw, M. Comparison of methods of assessment of renal function in cystic fibrosis (CF) patients. Journal of cystic fibrosis: official journal of the European Cystic Fibrosis Society 6, 41\u201347 (2007).","journal-title":"Journal of cystic fibrosis: official journal of the European Cystic Fibrosis Society"},{"key":"23466_CR43","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jcf.2009.12.002","volume":"9","author":"N Soulsby","year":"2010","unstructured":"Soulsby, N., Greville, H., Coulthard, K. & Doecke, C. What is the best method for measuring renal function in adults and children with cystic fibrosis? Journal of Cystic Fibrosis 9, 124\u2013129 (2010).","journal-title":"Journal of Cystic Fibrosis"},{"key":"23466_CR44","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/ki.2013.374","volume":"85","author":"PT Murray","year":"2014","unstructured":"Murray, P. T. et al. Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference. Kidney Int. 85, 513\u2013521, https:\/\/doi.org\/10.1038\/ki.2013.374 (2014).","journal-title":"Kidney Int."},{"key":"23466_CR45","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nrneph.2012.197","volume":"8","author":"M Haase","year":"2012","unstructured":"Haase, M., Kellum, J. A. & Ronco, C. Subclinical AKI\u2014an emerging syndrome with important consequences. Nature Reviews Nephrology 8, 735, https:\/\/doi.org\/10.1038\/nrneph.2012.197 (2012).","journal-title":"Nature Reviews Nephrology"},{"key":"23466_CR46","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jacc.2011.10.854","volume":"59","author":"TL Nickolas","year":"2012","unstructured":"Nickolas, T. L. et al. Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study. J. Am. Coll. Cardiol. 59, 246\u2013255, https:\/\/doi.org\/10.1016\/j.jacc.2011.10.854 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"23466_CR47","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1681\/ASN.2013070742","volume":"25","author":"SG Coca","year":"2014","unstructured":"Coca, S. G. et al. Urinary biomarkers of AKI and mortality 3 years after cardiac surgery. J. Am. Soc. Nephrol. 25, 1063\u20131071, https:\/\/doi.org\/10.1681\/ASN.2013070742 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"23466_CR48","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/ki.2015.115","volume":"88","author":"RL Mehta","year":"2015","unstructured":"Mehta, R. L. et al. Phenotype standardization for drug-induced kidney disease. Kidney Int. 88, 226\u2013234, https:\/\/doi.org\/10.1038\/ki.2015.115 (2015).","journal-title":"Kidney Int."},{"key":"23466_CR49","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1053\/j.ajkd.2015.04.040","volume":"67","author":"MP Schuh","year":"2016","unstructured":"Schuh, M. P. et al. Long-term Stability of Urinary Biomarkers of Acute Kidney Injury in Children. American journal of kidney diseases: the official journal of the National Kidney Foundation 67, 56\u201361, https:\/\/doi.org\/10.1053\/j.ajkd.2015.04.040 (2016).","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"},{"key":"23466_CR50","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/ki.2010.165","volume":"78","author":"SS Waikar","year":"2010","unstructured":"Waikar, S. S., Sabbisetti, V. S. & Bonventre, J. V. Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate. Kidney Int. 78, 486\u2013494 (2010).","journal-title":"Kidney Int."},{"key":"23466_CR51","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1542\/peds.58.2.259","volume":"58","author":"GJ Schwartz","year":"1976","unstructured":"Schwartz, G. J., Haycock, G. B., Edelmann, C. M. Jr. & Spitzer, A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58, 259\u2013263 (1976).","journal-title":"Pediatrics"},{"key":"23466_CR52","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.tox.2011.09.015","volume":"290","author":"DJ Antoine","year":"2011","unstructured":"Antoine, D. J. et al. Measurement of the urinary biomarker KIM-1 identifies the potential for aminoglycoside-induced nephrotoxicity in premature neonates. This issue includes Proceedings of the Annual Congress of The British Toxicology Society 290, 107, https:\/\/doi.org\/10.1016\/j.tox.2011.09.015 (2011).","journal-title":"This issue includes Proceedings of the Annual Congress of The British Toxicology Society"},{"key":"23466_CR53","unstructured":"R: A language and environment for statistical computing. (R Foundation for Statistical Computing, Vienna, Austria, 2011)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23466-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23466-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23466-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T03:41:36Z","timestamp":1671594096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23466-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,23]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["23466"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-23466-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,23]]},"assertion":[{"value":"17 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5094"}}